Dhingra, S.; Sachdeva, M. Expanding Horizons in the Treatment of Mantle Cell Lymphoma: Ibrutinib a Novel BTK-Targeting Inhibitor. Int J Basic Clin Pharmacol 2017, 3, 249-254.